Anti-PEPL/ PPL monoclonal antibody

Anti-PEPL/ PPL antibody for FACS & in-vivo assay

Target products collectionGo to PPL/PPL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2261-Ab-1/ GM-Tg-hg-MP2261-Ab-2Anti-Human PPL monoclonal antibodyHuman
GM-Tg-rg-MP2261-Ab-1/ GM-Tg-rg-MP2261-Ab-2Anti-Rat PPL monoclonal antibodyRat
GM-Tg-mg-MP2261-Ab-1/ GM-Tg-mg-MP2261-Ab-2Anti-Mouse PPL monoclonal antibodyMouse
GM-Tg-cynog-MP2261-Ab-1/ GM-Tg-cynog-MP2261-Ab-2Anti-Cynomolgus/ Rhesus macaque PPL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2261-Ab-1/ GM-Tg-felg-MP2261-Ab-2Anti-Feline PPL monoclonal antibodyFeline
GM-Tg-cang-MP2261-Ab-1/ GM-Tg-cang-MP2261-Ab-2Anti-Canine PPL monoclonal antibodyCanine
GM-Tg-bovg-MP2261-Ab-1/ GM-Tg-bovg-MP2261-Ab-2Anti-Bovine PPL monoclonal antibodyBovine
GM-Tg-equg-MP2261-Ab-1/ GM-Tg-equg-MP2261-Ab-2Anti-Equine PPL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2261-Ab-1/ GM-Tg-hg-MP2261-Ab-2; GM-Tg-rg-MP2261-Ab-1/ GM-Tg-rg-MP2261-Ab-2;
GM-Tg-mg-MP2261-Ab-1/ GM-Tg-mg-MP2261-Ab-2; GM-Tg-cynog-MP2261-Ab-1/ GM-Tg-cynog-MP2261-Ab-2;
GM-Tg-felg-MP2261-Ab-1/ GM-Tg-felg-MP2261-Ab-2; GM-Tg-cang-MP2261-Ab-1/ GM-Tg-cang-MP2261-Ab-2;
GM-Tg-bovg-MP2261-Ab-1/ GM-Tg-bovg-MP2261-Ab-2; GM-Tg-equg-MP2261-Ab-1/ GM-Tg-equg-MP2261-Ab-2
Products NameAnti-PPL monoclonal antibody
Formatmab
Target NamePPL
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PPL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PEPL/ PPL VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2261
    Target NamePPL
    Gene ID5493,19041,302934,710266,490021,101091989,522886,100069951
    Gene Symbol and SynonymsPPL
    Uniprot AccessionO60437
    Uniprot Entry NamePEPL_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000118898
    Target ClassificationN/A

    The target: PPL, gene name: PPL, also named as . The protein encoded by this gene is a component of desmosomes and of the epidermal cornified envelope in keratinocytes. The N-terminal domain of this protein interacts with the plasma membrane and its C-terminus interacts with intermediate filaments. Through its rod domain, this protein forms complexes with envoplakin. This protein may serve as a link between the cornified envelope and desmosomes as well as intermediate filaments. AKT1/PKB, a protein kinase mediating a variety of cell growth and survival signaling processes, is reported to interact with this protein, suggesting a possible role for this protein as a localization signal in AKT1-mediated signaling. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.